1st Quarter - Report

THE CHILDREN'S HOSPITAL OF PHILADELPHIA for THE CHILDREN'S HOSPITAL OF PHILADELPHIA

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally Food as Medicine nutrition programs generally Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally Pediatric vaccine policy and programs generally H.R. 1509 / S. 752 (Accelerating Kids' Access to Care Act), all provisions H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions

LobbyistCovered position, as disclosed
AHAVIAH DIANE GLASER —
PETER GROLLMAN —
SARAH GUERRIERI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 752 (119th), H.R. 2107 (119th), H.R. 1509 (119th)

Budget/Appropriations BUD

H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care Funding for cell and gene therapy generally

LobbyistCovered position, as disclosed
AHAVIAH DIANE GLASER —
PETER GROLLMAN —
SARAH GUERRIERI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1968 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.